Top 10 topics perceived as most useful to discuss in a consultation regarding discontinuation of antidepressant medication by patients and professionals, followed by their mean and rank order of priority scores
| Topics (top 10)a,b | Patients (n = 37) | Professionals (n = 27) | ||
|---|---|---|---|---|
| Mean | Rank | Mean | Rank | |
| Individual dose-reduction schedule (#22) | 4.43 | 1 | 3.96 | 7 |
| Relapse prevention (#50) | 4.27 | 2 | 4.11 | 4 |
| Current quality of life and psychological functioning (#6) | 4.16 | 3 | 3.74 | 12 |
| Fear of relapse (#11) | 4.03 | 4 | 3.96 | 8 |
| Advantages and disadvantages of discontinuing antidepressants (#3) | 4.03 | 5 | 3.74 | 13 |
| Regular counselling sessions to provide guidance (check-ups) (#43) | 4.00 | 6 | 3.67 | 14 |
| Time period and rate of dose reduction (phasing of the dosage) (#23) | 4.00 | 7 | 3.67 | 15 |
| Provide information about withdrawal symptoms (#17) | 3.95 | 8 | 4.30 | 1 |
| What options are there if things do not go well after you stop (#19) | 3.84 | 9 | 3.33 | 24 |
| Previous experiences with dose reduction (#21) | 3.78 | 10 | 4.19 | 2 |
| Current effect: What effect do you notice from the medicine (for example, calm, balanced, flat) and what do you think of that? (#12) | 3.65 | 12 | 4.11 | 5 |
| Expectations: What do you hope to achieve? (#1) | 3.65 | 13 | 3.93 | 10 |
| Reason(s) to stop taking antidepressants (#4) | 3.65 | 14 | 4.11 | 6 |
| Suicidality (#8) | 3.54 | 20 | 4.15 | 3 |
| Signalling plan: Which situations do not go so well, what happens, what can you do about it? (#18) | 3.51 | 23 | 3.93 | 9 |